Text Module

Share

Program Content

Activities

  • Chronic Myeloid Leukemia Treatment
    Chronic Myeloid Leukemia: Optimizing Use of TKIs to Individualize Treatment Across the Disease Spectrum
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 15, 2024

    Expires: February 14, 2025

Faculty

cover img faculity

Fadi Haddad, MD

Assistant Professor
Leukemia Department
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation.

Bristol Myers Squibb

Novartis Pharmaceuticals Corporation